Skip to main content
Product image

FOXO4-DRI 10mg

For Research Use Only (RUO) · Read our research disclaimer

≥99% Purity
€139.00€111.20Black Friday · −20 % on everything

Lowest price in the last 30 days: €139.00

4.7· 96 shop reviews
Black Friday · −20 % on everything
+ volume discount · free GHK-Cu from €350 · free Reta 10 mg from €550
applied automatically – no code needed
Why NovaCell
VisaMastercardApple PayBank transfer · Crypto −3%
4.7
96 shop reviews
5★75
4★15
3★3
2★3
1★0
Nick W.
received in 5 days, vials under vacuum and coa enclosed. a bit long but zero customs fees. product as described, already recommended
Translated
Elena H.
Already my third order — always top quality and well packed. Delivery quick in 3-5 days. Customer support is friendly, fast and helpful.
See all 96 reviews →
€105.60 each
3 vials · 10 mg · you save €79.20
EU Stock – 2–6 business day EU shippingFree shipping over €115
Ordering information

For bank transfers, use the amount and payment reference in your order confirmation. An order is paid only once receipt of payment is confirmed.

Check delivery coverage, shipping costs and delivery times. Review availability and preorder notices for the selected variant.

For qualified laboratory research only (RUO). Not for use in humans or animals.

Bacteriostatic Water
Free with order

Free Bacteriostatic Water

Included with every peptide order

Overview: FOXO4-DRI (also known as FOXO4-D-Retro-Inverso, ProxofimTM-Analog) is a D-amino acid retro-inverso peptide, developed by the research group of Peter L. J. de Keizer (Nature 2017). Category: Cell Ageing & Senolytics Research. It is designed for the selective disruption of the p53–FOXO4 protein-protein interaction in senescent cells.

Research Purpose: For investigating the selective elimination of senescent cells (SASP modulation), analysing p53 nucleolus/cytoplasm translocation, studying cellular senescence reversion (p21, SA-β-Gal, γH2AX) and for in vitro models of age-associated pathologies.

Specifications: ≥95% purity (HPLC + LC-MS). Features D-amino acid sequence (retro-inverso) for maximum protease resistance. Lot tracking, lyophilized. COA included. 100% EU shipping guarantee – free replacement delivery in case of loss or damage.

Research Purpose

  • Senolytics Research: Analysis of selective apoptosis of senescent cells and p53-FOXO4 disruption.
  • Cellular Senescence: Studies on SA-β-Galactosidase, p21^CIP1, γH2AX foci and SASP cytokine profiles.
  • Protein Interaction: In vitro assays for disrupting transcription factor interactions in the nucleolus/cytoplasm.
  • Peptide Chemistry: Reference peptide for D-retro-inverso design strategies with increased proteolytic stability.
  • Purity ≥95% verified by HPLC
  • D-Retro-Inverso sequence (D-amino acids)
  • Maximum protease resistance
  • Reference peptide for senolytics research
  • Full batch traceability

Frequently asked questions

What is FOXO4-DRI?

FOXO4-DRI is a D-amino acid retro-inverso peptide designed to disrupt the p53–FOXO4 interaction in senescent cells. It was originally described by de Keizer's group (Nature 2017) and serves as a reference tool in senolytics research.

Why D-Retro-Inverso?

D-amino acids in a retro-inverso sequence retain the spatial orientation of side chains but are largely stable against proteases, which significantly extends in vitro half-life and bioavailability in cell assays.

Which endpoints are investigated in FOXO4-DRI studies?

Typical in vitro endpoints include SA-β-Galactosidase activity, p21^CIP1 expression, γH2AX foci, SASP cytokine profiles (IL-6, IL-8, MMP-3), and p53 nucleolus/cytoplasm translocation in senescent cell models.

Is FOXO4-DRI the same as Proxofim?

Proxofim is the trade name given by a startup to a FOXO4-DRI analog. FOXO4-DRI refers to the peptide sequence itself, as described in de Keizer et al. (Nature 2017). NovaCell provides the peptide exclusively as an RUO reference tool.

Is FOXO4-DRI intended for use in humans?

No. FOXO4-DRI from NovaCell is strictly for Research Use Only and is not approved for therapeutic or diagnostic applications.

Batch record: every lab report

Every batch is analysed before it is sold. These are all published reports for this product – with report number, date and a PDF you can check.

BatchReport no.DatePurity (HPLC)EndotoxinLabPDF
FX-082604Lyo-0826Sep 2026>99.8%–Liquilabs PDF

View all lab reports

Analyses by external, independent testing laboratories (Liquilabs). Every report has its own analysis number and can be viewed as a PDF or on the lab's verification page.

Supplier: NCBL Sciences OÜ (Estonia), registry code 17455124 · shipped from our EU warehouse in Poland.

All products strictly for research and laboratory use (RUO).

Peptides from the same research category – HPLC + LC-MS tested, with COA.

Deepen the topic with matching comparisons, related peptides and trust resources.

For Research Use Only (RUO). Not for human consumption or veterinary use. No medical recommendations. Full Disclaimer

Cart

Your cart is empty

Buy Research Peptides